- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Rajesh Rajpal on Recovery From Cataract Surgery, Employer Considerations
Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, speaks on the timeline of recovery for patients with cataract undergoing corrective surgery.
Recovery from cataract surgery typically allows patients to still function and be able to complete light tasks in the first week, with patients able to resume normal schedules after this time, said Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson (J&J) Vision.
Transcript
For employers considering coverage of cataract surgery in their health plan, can you speak on the procedure’s recovery time?
Fortunately, cataract surgery is a relatively rapid recovery. It's outpatient surgery done under anesthesia that is topical, often with a mild sedative for the patient. And they can typically, by the next day, be able to still function and do daily activities with light, strenuous range, because they can still function with their other eye even while they're healing.
Usually it's just a day or 2 of down time, but then we ask patients to take it easy for the first week or so and then they're pretty much back to normal. Most commonly, patients will have surgery on each eye a week or two apart.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
